tetrahydro-4-hydroxy-6-[2-(1 h -pyrrol-1-yl)ethyl]-2 h -pyran-2-one inhibitors of hmg-coa reductase.
in contrast, the enantiomer patent claims only the r enantiomer.
the enantiomer patent 161 the enantiomer patent is entitled '[r---(r*r*)]---2---(4---fluorophenyl) ---&szlig;, &#948;---dihydroxy---5---(1---methylethyl---3---phenyl---4---(phenylamino)carbonyl]---1h---pyrrole---1---heptanoic acid, its lactone form and salts thereof'.